Inventor · disambiguated record
Urs Beat Hagemann
Also filed as: HAGEMANN URS · HAGEMANN URS BEAT
9 granted patents·6 pending applications·41 citations·filing 2010–2023
84Inventor score
Top patents by PatentIndex Score
15 records- 0196US9475885B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2015·Granted Oct 25, 2016·15 cites·31 claims
- 0291US9011860B2Compositions for inhibiting MASP-2 dependent complement activationDUDLER THOMAS·Filed 2012·Granted Apr 21, 2015·20 cites·24 claims
- 0383US2024092938A1Compositions for inhibiting masp-2 dependent complement activationOMEROS CORP·Filed 2023·Application pending·0 cites
- 0478US8969253B2Method for screening phage display libraries against each otherREIERSEN HERALD·Filed 2010·Granted Mar 3, 2015·5 cites·18 claims
- 0573US11613589B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2020·Granted Mar 28, 2023·0 cites·13 claims
- 0670US10683367B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2018·Granted Jun 16, 2020·0 cites·33 claims
- 0764US10047165B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2016·Granted Aug 14, 2018·0 cites·9 claims
- 0862US8895007B2Antibodies which bind to the human CC chemokine receptor 4 and uses thereofHAGEMANN URS BEAT·Filed 2011·Granted Nov 25, 2014·1 cites·13 claims
- 0958US2025319216A1Radiopharmceutical complexes targeting prostate-specific membrane antigen and its combinationsBAYER AG·Filed 2023·Application pending·0 cites
- 1056US9458238B2Nucleic acid molecules encoding antibodies which bind CCR4 and uses thereofAFFITECH RES AS·Filed 2014·Granted Oct 4, 2016·0 cites·12 claims
- 1156US2024108766A1Lrrc15 antibodies and conjugates thereofBAYER AG·Filed 2022·Application pending·0 cites
- 1250US2021187134A1Combination of pi3k-inhibitors and targeted thorium conjugatesBAYER AS·Filed 2019·Application pending·0 cites
- 1346US2022125960A1Combination of pd-1/pd-l1 inhibitors and targeted thorium conjugatesBAYER AG·Filed 2020·Application pending·0 cites
- 1445US2022118123A1Combination of ar antagonists and targeted thorium conjugatesBAYER AG·Filed 2020·Application pending·0 cites
- 1544US10266599B2Antibodies which bind to the human CC chemokine receptor 4 and uses thereofCANCER RESEARCH TECH LTD·Filed 2016·Granted Apr 23, 2019·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when Urs Beat Hagemann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →